Form: SC 13G

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

October 4, 2018

Documents

 

EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Sutro Biopharma Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.

 

This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.

 

Dated this 4th day of October, 2018.

 

CITADEL ADVISORS LLC   CITADEL ADVISORS HOLDINGS LP
         
By: /s/ David Glockner   By: /s/ David Glockner
  David Glockner, Authorized Signatory     David Glockner, Authorized Signatory
         
CITADEL GP LLC   KENNETH GRIFFIN
         
By: /s/ David Glockner   By: /s/ David Glockner
  David Glockner, Authorized Signatory     David Glockner, attorney-in-fact*

 

 

 

 

 

 

 

 

________________

* David Glockner is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Roku, Inc. on January 17, 2018.